Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $142.1M
Liabilities Breakdown FY2012
Total Liabilities: $33.1M
Asset Breakdown
Total Assets: $142.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $44.1M | 31.0% |
| Accounts Receivable | $21.5M | 15.1% |
| Inventory | $8.3M | 5.8% |
| Property, Plant & Equipment | $35.1M | 24.7% |
| Goodwill | $9.1M | 6.4% |
| Intangible Assets | $20.3M | 14.3% |
| Other Assets | $3.7M | 2.6% |
Liabilities Breakdown
Total Liabilities: $33.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 7.1% |
| Long-Term Debt | $8.0M | 24.1% |
| Other Liabilities | $22.8M | 68.8% |